Comparison of nodal positivity between SLNM vs conventional surgery in colon cancer patients with <12 and ≥12 lymph nodes harvested

American Journal of Surgery

Volumn 202, Issue 2, 2011, Pages 207-213

  Soni, Mehul ^a   Wiese, David ^a   Korant, Alpesh ^a   Sirop, Saad ^a   Chakravarty, Bishan ^a   Gayar, Adam ^a   Bilchik, Anton ^b   Beutler, Thomas ^c   Ratz, David ^d   Saha, Sukamal ^a  

^a MCLAREN REGIONAL MEDICAL CENTER   (United States)

^b JOHN WAYNE CANCER INSTITUTE   (United States)

^c Faith Regional Carson Cancer Center   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Colon cancer; Nodal positivity; Sentinel node

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; COLON CANCER; FEMALE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE;

ADULT; AGED; ANALYSIS OF VARIANCE; COLONIC NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; QUALITY ASSURANCE, HEALTH CARE; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; UNITED STATES;

EID: 79960997450     PISSN: 00029610     EISSN: 18791883     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2010.06.028     Document Type: Article

References (25)

1. Chang G, Rodriguez-Bigas M, Skibber J. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst 2007;99:433-41. (Pubitemid 47073566)
2. Ragnhammar P, Hafstom L, Nygren P, et al. A systematic overview of chemotherapy effects in colorectal cancer. Acta Oncol 2001;40:282-308. (Pubitemid 32588124)
3. Taal BG, Van Tinteren H, Zoetmulder FA. Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stages II and III. Br J Cancer 2001;85:1437-43. (Pubitemid 34001570)
4. Gill S, Loprinizi C, Sargent D, et al. Pooled analysis of fluorouracilbased adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J Clin Oncol 2004;22:1797-806. (Pubitemid 41095169)
5. Vather R, Sammour T, Kahokehr A. Lymph node evaluation and long-term survival in stage II and stage III colon cancer: a national study. Ann Surg Oncol 2009;16:585-93.
6. Le Voyer T, Sigurdson E, Hanlon A, et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol 2003;21:2912-9. (Pubitemid 46621841)
7. Prandi M, Lionetto R, Francioni G, et al. Prognostic evaluation of stage B colon cancer patients is improved by an adequate lymphadenectomy: results of a secondary analysis of a large scale adjuvant trial. Ann Surg 2002;235:458-63. (Pubitemid 34258343)
8. Jestin P, Pahlman L, Glimelius B, et al. Cancer staging and survival in colon cancer is dependent on the quality of the pathologists' specimen examination. Eur J Cancer 2005;41:2071-8. (Pubitemid 41337948)
9. Caplin S, Cerottini J, Bosman F, et al. For patients with Dukes' B (TNM stage II) colorectal carcinoma, examination of sex or fewer lymph nodes is related to poor prognosis. Cancer 1998;83:666-72. (Pubitemid 28387688)
10. Gummus M, Yumuk P, Atalay G, et al. What is the optimal number of lymph nodes to be dissected in colorectal cancer surgery? Tumori 2005;91:168-72.
11. Ratto C, Sofo L, Ippoliti M, et al. Accurate lymph node detection in colorectal specimens resected for cancer is of prognostic significance. Dis Colon Rectum 1999;42:143-58. (Pubitemid 29085149)
12. Tsikitis V, Larson D, Wolff B, et al. Survival in stage III colon cancer is independent of the total number of lymph nodes retrieved. Ann Surg 2009;208:42-7.
13. Rosenberg R, Friederichs J, Schuster T, et al. Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single center analysis of 3026 patients over a 25 year time period. Ann Surg 2008;248:968-78.
14. National Quality Forum. Specifications of the national voluntary consensus standards for breast and colon cancer. Available at: http://www.qualityforum.org/pdf/cancer/txbreast-colonAppA-Specsvoting01-18- 07clean.pdf. Accessed October 9, 2007.
15. National Quality Forum endorsed Commission on Cancer measures for quality of cancer care for breast and colorectal cancers (press release). Chicago, IL: American College of Surgeons Commission on Cancer; 2007.
16. Bilimoria K, Bentram D, Stewart K. Lymph node evaluation as a colon cancer quality measure: a national hospital report card. J Natl Cancer Inst 2008;100:1310-7.
17. Saha S, Seghal R, Patel M, et al. A multicenter trial of sentinel lymph node mapping in colorectal cancer: prognostic implications for nodal staging and recurrence. Am J Surg 2006;191:305-10. (Pubitemid 43265995)
18. Saha S, Ganatra BK, Gauthier J, et al. Localization of sentinel lymph node in colon cancer: a feasibility study. Soc Surg Oncol 50th Annu Cancer Symp 1997;54:80.
19. Saha S, et al. Survival benefits after sentinel lymph node mapping as compared to conventional surgery. Abstract presented at: Society of Surgical Oncology 62nd Annual Cancer Symposium. March 4-8, 2009 in Phoenix, AZ.
20. Iddings D, Ahmad A, Elashoff D, et al. The prognostic effect of micrometastasis in previously staged lymph node negative (N0) colorectal carcinoma: a meta-analysis. Ann Surg Oncol 2006;13:1386-92.
21. Bilimoria K, Palis B, Steward A, et al. Impact of tumor location on nodal evaluation for colon cancer. Dis Colon Rectum 2008;51:154-6.
22. Monig SP, Baldus S, Zirbes TK, et al. Lymph node size and metastatic infiltration in colon cancer. Ann Surg Oncol 1999;6:579-81. (Pubitemid 29428798)
23. Sanchez-Maldonado W, Rodriguez-Bigas M, Weber T, et al. Utility of mapping lymph nodes cleared from rectal adenocarcinoma specimens. Surg Oncol 1996;5:123-6. (Pubitemid 26385512)
24. Murphy J, O'Sullivan G, Fitzgibbon J, et al. The effect of node size on the detection of nodal metastases in Dukes C rectal carcinoma. Gut 1999;44(suppl):A84.
25. Saha S, Sirop S, Viehl CT, et al. An international experience of causes and biological relevance of skip metastasis after sentinel lymph node mapping in colon cancer. Presented at: Society of Surgical Oncology 62nd Annual Cancer Symposium.